5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.00▼ | 1.00▼ | 1.00▼ | 0.83▲ | 0.83▲ |
MA10 | 1.01▼ | 1.01▼ | 0.94▲ | 0.83▲ | 0.86▲ |
MA20 | 1.00▼ | 0.92▲ | 0.87▲ | 0.81▲ | 0.91▲ |
MA50 | 0.94▲ | 0.83▲ | 0.83▲ | 0.88▲ | 1.30▼ |
MA100 | 0.85▲ | 0.84▲ | 0.83▲ | 0.92▲ | 3.65▼ |
MA200 | 0.88▲ | 0.83▲ | 0.82▲ | 1.07▼ | 4.03▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | 0.004▲ | 0.019▲ | 0.020▲ | 0.049▲ |
RSI | 52.592▲ | 65.347▲ | 68.739▲ | 61.501▲ | 46.646▼ |
STOCH | 53.634 | 61.838 | 80.647▲ | 23.580 | 20.567 |
WILL %R | -85.920▼ | -27.566 | -24.163▲ | -34.333 | -45.028 |
CCI | -91.970 | 38.394 | 71.597 | 184.066▲ | -7.384 |
Thursday, August 14, 2025 03:41 AM
Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 – – On track to dose first participant in Phase ...
|
Wednesday, August 06, 2025 04:09 AM
Shattuck Labs yesterday announced that it has entered into a securities purchase agreement for a private placement financing ...
|
Tuesday, August 05, 2025 11:43 AM
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and therefore flagged by the Imperva network. Imperva displays this page for you ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.91 | 1.07 | 0.8743 | 1.00 | 1,753,786 |
14/08/25 | 0.80 | 0.874 | 0.79 | 0.8604 | 500,489 |
13/08/25 | 0.76 | 0.83 | 0.76 | 0.8107 | 499,460 |
12/08/25 | 0.74 | 0.77 | 0.7131 | 0.7625 | 320,506 |
11/08/25 | 0.73 | 0.7996 | 0.73 | 0.7392 | 385,123 |
08/08/25 | 0.79 | 0.8124 | 0.73 | 0.7563 | 682,189 |
07/08/25 | 0.79 | 0.8607 | 0.774 | 0.7809 | 765,180 |
06/08/25 | 0.89 | 0.9299 | 0.7602 | 0.8188 | 2,809,911 |
05/08/25 | 1.00 | 1.15 | 0.9133 | 0.99 | 93,764,869 |
04/08/25 | 0.74 | 0.7999 | 0.74 | 0.7427 | 14,499 |
|
|
||||
|
|
||||
|
|